Related references
Note: Only part of the references are listed.The role of TNF-α and anti-TNF-α agents in the immunopathogenesis and management of immune dysregulation in primary immunodeficiency diseases
Sharafudeen Dahiru Abubakar et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2022)
Role of Exosomal miR-223 in Chronic Skeletal Muscle Inflammation
Yuan Tian et al.
ORTHOPAEDIC SURGERY (2022)
Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
John Zizzo
CURRENT PHARMACEUTICAL DESIGN (2021)
Divergent Roles of Inflammation in Skeletal Muscle Recovery From Injury
Emily E. Howard et al.
FRONTIERS IN PHYSIOLOGY (2020)
Inflammation and Skeletal Muscle Regeneration: Leave It to the Macrophages!
Benedicte Chazaud
TRENDS IN IMMUNOLOGY (2020)
Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice
Clara Sciorati et al.
Aging-US (2020)
Inflammation and Skeletal Muscle Wasting During Cachexia
Justine M. Webster et al.
FRONTIERS IN PHYSIOLOGY (2020)
Fibro-Adipogenic Progenitors Cross-Talk in Skeletal Muscle: The Social Network
Beatrice Biferali et al.
FRONTIERS IN PHYSIOLOGY (2019)
Canonical NF-B signaling regulates satellite stem cell homeostasis and function during regenerative myogenesis
Alex R. Straughn et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
Fibro-adipogenic progenitors of dystrophic mice are insensitive to NOTCH regulation of adipogenesis
Milica Marinkovic et al.
LIFE SCIENCE ALLIANCE (2019)
A systematic review of p53 regulation of oxidative stress in skeletal muscle
Kaitlyn Beyfuss et al.
REDOX REPORT (2018)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
The underlying inflammatory chronic disease influences infliximab pharmacokinetics
Christophe Passot et al.
MABS (2016)
Cytokine Signaling in Skeletal Muscle Wasting
Jin Zhou et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease
K. Subramaniam et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Small Molecules as Anti-TNF Drugs
Victoria Richmond et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors
Dario R. Lemos et al.
NATURE MEDICINE (2015)
TNF-α and TNFR1 responses to recovery therapies following acute resistance exercise
Jeremy R. Townsend et al.
FRONTIERS IN PHYSIOLOGY (2015)
Current understanding of sarcopenia: possible candidates modulating muscle mass
Kunihiro Sakuma et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations
Marinos C. Dalakas
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size
Rachel Nilwik et al.
EXPERIMENTAL GERONTOLOGY (2013)
Clinical Use and Mechanisms of Infliximab Treatment on Inflammatory Bowel Disease: A Recent Update
Yuan Guo et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Melatonin restores muscle regeneration and enhances muscle function after crush injury in rats
Ioannis Stratos et al.
JOURNAL OF PINEAL RESEARCH (2012)
Infliximab Treatment Increases Left Ventricular Ejection Fraction in Patients with Rheumatoid Arthritis: Assessment of Heart Function by Echocardiography, Endothelin 1, Interleukin 6, and NT-pro Brain Natriuretic Peptide
Przemyslaw J. Kotyla et al.
JOURNAL OF RHEUMATOLOGY (2012)
Intravenous immunoglobulin for myasthenia gravis
Philippe Gajdos et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Tumor Necrosis Factor-Alpha Antagonist Administration Recovers Skeletal Muscle Dysfunction in Ovariectomized Rats
Sezin Dagdeviren et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
Blockade of TNF in vivo using cVlq antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice
A. T. Piers et al.
NEUROMUSCULAR DISORDERS (2011)
Infliximab administration reduces neuronal apoptosis on the optic pathways in a rabbit hydrocephalus Model: A preliminary report
Gokhan Kurt et al.
BRITISH JOURNAL OF NEUROSURGERY (2010)
Open Blunt Crush Injury of Different Severity Determines Nature and Extent of Local Tissue Regeneration and Repair
Ioannis Stratos et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2010)
Dual Role of Intravitreous Infliximab in Experimental Choroidal Neovascularization: Effect on the Expression of Sulfated Glycosaminoglycans
Caio V. Regatieri et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
TNFα blockade in human diseases:: Mechanisms and future directions
Maida Wong et al.
CLINICAL IMMUNOLOGY (2008)
Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment
Hannah G. Radley et al.
NEUROMUSCULAR DISORDERS (2008)
The Inflammatory Response to Skeletal Muscle Injury Illuminating Complexities
Carine Smith et al.
SPORTS MEDICINE (2008)
Catabolic mediators of cancer cachexia
Michael J Tisdale
Current Opinion in Supportive and Palliative Care (2008)
Infliximab restores glucose Homeostasis in an animal model of diet-induced obesity and diabetes
Eliana P. Araujo et al.
ENDOCRINOLOGY (2007)
TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK
Shuen-Ei Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
A clinical and immunological study of a myasthenia gravis patient treated with infliximab
M. Kakoulidou et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Clinical pharmacokinetics and use of infliximab
Ulrich Klotz et al.
CLINICAL PHARMACOKINETICS (2007)
Silencing TNFα activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts:: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice
MD Grounds et al.
CELL AND TISSUE RESEARCH (2005)
TNF-α is a mitogen in skeletal muscle
YP Li
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Alterations in contractile properties of human skeletal muscle induced by joint immobilization
K Seki et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
J Inoue et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
